Department of Biochemistry, All India Institute of Medical Sciences, New Delhi, India.
FEBS J. 2011 Sep;278(18):3256-76. doi: 10.1111/j.1742-4658.2011.08275.x.
Dipeptidyl peptidase III (DPP III), the sole member and representative of the M49 family of metallopeptidases, is a zinc-dependent aminopeptidase. It sequentially hydrolyses dipeptides from the N-terminal of oligopeptides ranging from three to 10 amino acid residues. Although implicated in an array of pathophysiological phenomena, the precise function of this peptidase is still unclear. However, a number of studies advocate its contribution in terminal stages of protein turnover. Altered expression of DPP III which suggests its involvement in primary ovarian carcinoma, oxidative stress (Nrf2 nuclear localization), pain, inflammation and cataractogenesis has recently led to resurgence of interest in delineating the role of the peptidase in these pathophysiological processes. This review article intends to bring forth the latest updates in this arena which may serve as a base for future studies on the peptidase.
二肽基肽酶 III(DPP III)是 M49 家族金属肽酶的唯一成员和代表,是一种锌依赖性氨肽酶。它从三到十个氨基酸残基的寡肽的 N 末端顺序水解二肽。尽管该肽酶与多种病理生理现象有关,但确切的功能仍不清楚。然而,许多研究主张它在蛋白质转化的末端阶段发挥作用。DPP III 的表达改变表明其参与原发性卵巢癌、氧化应激(Nrf2 核定位)、疼痛、炎症和白内障形成,这使得人们对该肽酶在这些病理生理过程中的作用重新产生了兴趣。本文旨在介绍该领域的最新进展,为该肽酶的未来研究提供基础。